Seeking Alpha
2
All posts from Seeking Alpha
Seeking Alpha in Seeking Alpha - Read, Decide, Invest.,

Bet The Farm On Gilead... Again

Harvoni (Source: gilead.com)

During the Q3 earnings season, I advised investors to bet the farm on Gilead Sciences (NASDAQ:GILD). However, I may have been a little premature after the company disappointed the market on top line sales growth. On Tuesday, Gilead reports its Q4 earnings. Analysts are expecting revenue of $6.73 billion and earnings per share ("EPS") of $2.20. Revenue estimates imply 11% growth sequentially. Gilead is a biopharmaceutical company that develops and markets antiviral drugs. Areas of focus are human immunodeficiency virus ("HIV"), liver diseases such as hepatitis B ("HBV") infection, hepatitis C ("HCV") infection, and respiratory and cardiovascular…